Glaucoma

Folgen
Researchers at the University of Missouri in a lab studying agmatine and thiamine as biomarkers for early glaucoma detection, with vials and eye scans visible.
Bild generiert von KI

Mizzou researchers identify molecules for early glaucoma detection

Von KI berichtet Bild generiert von KI Fakten geprüft

Scientists at the University of Missouri report that two natural molecules — agmatine and thiamine — are reduced in samples from glaucoma patients and could serve as early biomarkers. In preclinical work, the compounds also showed signs of protecting retinal cells, suggesting a path to earlier detection and potential neuroprotective therapies.

Diese Website verwendet Cookies

Wir verwenden Cookies für Analysen, um unsere Website zu verbessern. Lesen Sie unsere Datenschutzrichtlinie für weitere Informationen.
Ablehnen